Orphan Drugs Webinar
Are They Losing Their Sparkle?

Wednesday 29th May 3pm BST | 10am EST
For ten years, orphan drugs have doubled their market share in global prescription drug sales, surpassing non-orphan drugs. However, their once bright gloss is beginning to dull, and their growth advantage is diminishing. 
Sign up for our webinar to discover the reasons behind this shift and what the future may hold.

Get expert insights on:

  • Major players in the field
  • Exciting therapy areas
  • Technologies primed to drive growth
  • Rare diseases' significance for big pharma
  • What's piquing investors' interest?
  • The impact of new legislation on R&D pipelines

Your Hosts:

Melanie Senior,
Author, Orphan Drug Report
Stephanie Léouzon,
Managing Director, Biopharma Healthcare, 
Puru Gaur,
Senior Commercial Analyst, Evaluate